These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19482023)
1. ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization. Kociok N; Radetzky S; Krohne TU; Gavranic C; Liang Y; Semkova I; Joussen AM Exp Eye Res; 2009 Oct; 89(4):503-10. PubMed ID: 19482023 [TBL] [Abstract][Full Text] [Related]
2. Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Kociok N; Radetzky S; Krohne TU; Gavranic C; Joussen AM Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5057-65. PubMed ID: 17065527 [TBL] [Abstract][Full Text] [Related]
3. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Kociok N; Krohne TU; Poulaki V; Joussen AM Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710 [TBL] [Abstract][Full Text] [Related]
4. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012 [TBL] [Abstract][Full Text] [Related]
6. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2. Dal Monte M; Ristori C; Cammalleri M; Bagnoli P Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858 [TBL] [Abstract][Full Text] [Related]
7. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Pierce EA; Foley ED; Smith LE Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081 [TBL] [Abstract][Full Text] [Related]
8. The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy. Feng Y; Vom Hagen F; Wang Y; Beck S; Schreiter K; Pfister F; Hoffmann S; Wagner P; Seeliger M; Molema G; Deutsch U; Hammes HP Thromb Haemost; 2009 Jul; 102(1):120-30. PubMed ID: 19572076 [TBL] [Abstract][Full Text] [Related]
9. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-B and retinal vascular development in the mouse. Reichelt M; Shi S; Hayes M; Kay G; Batch J; Gole GA; Browning J Clin Exp Ophthalmol; 2003 Feb; 31(1):61-5. PubMed ID: 12580897 [TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization. Fei P; Palenski TL; Wang S; Gurel Z; Hankenson KD; Sorenson CM; Sheibani N J Ocul Pharmacol Ther; 2015 Sep; 31(7):429-44. PubMed ID: 25950258 [TBL] [Abstract][Full Text] [Related]
12. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR). Scott A; Powner MB; Fruttiger M Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal Delivery of VEGF-A Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455 [TBL] [Abstract][Full Text] [Related]
14. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy. Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639 [TBL] [Abstract][Full Text] [Related]
15. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101 [TBL] [Abstract][Full Text] [Related]
16. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764 [TBL] [Abstract][Full Text] [Related]
17. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091 [TBL] [Abstract][Full Text] [Related]
19. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062 [TBL] [Abstract][Full Text] [Related]
20. VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the Royal College of Surgeons rat. Prokosch V; Fink J; Heiduschka P; Melkonyan H; Thanos S Exp Eye Res; 2011 Feb; 92(2):128-37. PubMed ID: 21147101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]